Lung cancer screening white paper: a slippery step forward?

Kauczor Hans-Ulrich, Bonomo Lorenzo, Gaga Mina, Nackaerts Kristiaan, Peled Nir, Prokop Mathias, Remy-Jardin Martine, von Stackelberg Oyunbileg, Sculier Jean-Paul

Source: Eur Respir J 2015; 46: 1521-1522
Journal Issue: November

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Kauczor Hans-Ulrich, Bonomo Lorenzo, Gaga Mina, Nackaerts Kristiaan, Peled Nir, Prokop Mathias, Remy-Jardin Martine, von Stackelberg Oyunbileg, Sculier Jean-Paul. Lung cancer screening white paper: a slippery step forward?. Eur Respir J 2015; 46: 1521-1522

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Implementation of lung cancer screening in Europe: the way forward
Source: Virtual Congress 2020 – Thoracic oncology
Year: 2020


ESR/ERS white paper on lung cancer screening
Source: Eur Respir J 2015; 46: 28-39
Year: 2015



ESR/ERS statement paper on lung cancer screening
Source: Guideline 2020
Year: 2020

ESR/ERS statement paper on lung cancer screening
Source: Eur Respir J, 55 (2) 1900506; 10.1183/13993003.00506-2019
Year: 2020



Screening for lung cancer through a nation-wide program - lessons learned and moving forward
Source: International Congress 2017 – State of the art session: "Lung cancer"
Year: 2017


Lung cancer screening: the critical review
Source: International Congress 2015 – Lung cancer screening: how to implement a comprehensive preventive approach
Year: 2015



Immunotherapy in SCLC: small step or leap?
Source: Virtual Congress 2020 – Exciting new developments in lung cancer screening, diagnostics and treatment
Year: 2020

Lung cancer screening - what does it mean for our practice?
Source: Virtual Congress 2020 – Screening and imaging in lung cancer
Year: 2020




A network lung cancer pathway in review: Are we choosing the right diagnostic approach?
Source: Annual Congress 2010 - Quality management for lung cancer patients
Year: 2010


Is our approach to basic research right? Pitfalls and successes: what is the way forward?
Source: ERS Research Seminar 2016
Year: 2016

Panel discussion: Improving the pathway of lung cancer patients, can we do it better?
Source: ERS webinar 2021: Panel discussion on improving the pathway of lung cancer patients, can we do it better?
Year: 2021


Cannabis use and lung cancer: time to stop overlooking the problem?
Source: Eur Respir J, 57 (5) 2004132; 10.1183/13993003.04132-2020
Year: 2021



Lung cancer screening in never-smokers: facts and remaining issues
Source: Eur Respir J, 56 (5) 2002949; 10.1183/13993003.02949-2020
Year: 2020



Single Slide Assessment: the future of molecular testing in lung cancer?
Source: International Congress 2017 – Clinical research in lung cancer: new valuable results on lung cancer detection, prognostic biomarkers, and tyrosine kinase inhibitors
Year: 2017

Is CT-based screening for lung cancer finally ready for prime time?
Source: Annual Congress 2012 - PG18 Recent evolutions in screening and early diagnosis of lung cancer
Year: 2012



Lung cancer: what are the genetic and genomic perspectives?
Source: International Congress 2016 – Molecular footprints in lung cancer diagnosis and management
Year: 2016


Lung cancer: keep your mind open – it's not always the usualsuspects!
Source: Breathe, 16 (1) 190363; 10.1183/20734735.0363-2019
Year: 2020



Lung cancer assessment clinics: the fast track to bad news?
Source: Eur Respir J 2005; 26: Suppl. 49, 323s
Year: 2005

Lung cancer: only tobacco-smoking?
Source: Annual Congress 2004 - Occupational Grand Round, an interactive session
Year: 2004